Acquisitions (Consideration Transferred) (Detail) - ARTeSYN Biosolutions - USD ($) $ in Thousands		12 Months Ended
	Oct. 27, 2020	Dec. 31, 2020
Business Acquisition [Line Items]
Cash consideration		$ 130,713
Equity consideration	$ 70,000	69,422
Contingent consideration		1,548
Settlement of preexisting liabilities		2,310
Fair value of net assets acquired	$ 200,000	$ 203,993